Shi Yongxiang, Chen Weishan, Li Qinghuai, Ye Zhaoming
Department of Orthopaedic Surgery, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Department of Medicine, 3rd Hospital of Henan Province, Henan, China.
Oncotarget. 2016 Oct 18;7(42):68151-68155. doi: 10.18632/oncotarget.11902.
The androgen receptor (AR) is involved in the differentiation and growth of many cancers. We hypothesized that two microsatellite polymorphic variants, AR (CAG)n and (GGN)n repeats, were also associated with the development of Papillary thyroid cancer (PTC) and Osteosarcoma. In current study, we conducted two case-control studies in a Chinese population to investigate the possible relationship between these two AR repeat polymorphisms and the risk of PTC and Osteosarcoma. The AR CAG repeat length was significantly associated with both risk of PTC and Osteosarcoma. Subjects with shorter AR CAG repeats had a higher risk of developing PTC (OR = 1.47, 95% CI: 1.17-1.85, P = 0.001) and Osteosarcoma (OR = 1.53, 95% CI: 1.19-1.97, P = 9.2 x 10-4). Specifically, shorter GGN repeats also contribute a significant increased risk of Osteosarcoma (OR = 1.35, 95% CI: 1.03-1.77, P = 0.030). Our results contribute to a better understanding of the complex hormone related mechanisms underlying PTC and Osteosarcoma.
雄激素受体(AR)与多种癌症的分化和生长有关。我们推测,两种微卫星多态性变体,即AR(CAG)n和(GGN)n重复序列,也与甲状腺乳头状癌(PTC)和骨肉瘤的发生有关。在当前的研究中,我们在中国人群中进行了两项病例对照研究,以调查这两种AR重复多态性与PTC和骨肉瘤风险之间的可能关系。AR CAG重复长度与PTC和骨肉瘤的风险均显著相关。AR CAG重复序列较短的受试者患PTC(OR = 1.47,95% CI:1.17 - 1.85,P = 0.001)和骨肉瘤(OR = 1.53,95% CI:1.19 - 1.97,P = 9.2×10 - 4)的风险更高。具体而言,较短的GGN重复序列也显著增加了骨肉瘤的风险(OR = 1.35,95% CI:1.03 - 1.77,P = 0.030)。我们的结果有助于更好地理解PTC和骨肉瘤潜在的复杂激素相关机制。